P/B
—
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
$3M
Market Cap • 9/29/2026
2020
(6 years)
Founded
2023
(3 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
1,2
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
—
EPS
—
Market Cap
Market Cap
3M
EV
-10,7M
EV/Revenue
-4,1
EV/EBITDA
0,9
EV/EBIT
0,9
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-1041,2%
Total Yield
-1041,2%
Payout
0%
Retained Earnings
-28,9M
Profitability
Gross Margin
31,1%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
15,7%
Capex/Revenue
30,2%
Capex/D&A
135,4%
Capex/OCF
-9,5%
SBC/OCF
—
% PPE
18,3%
% Goodwill
8,3%
ROE
—
ROIC
—
Leverage
N.D./EBITDA
1,2
Debt/Equity
0%
Current Ratio
1,4
Quick Ratio
1,3
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!